In addition, since HLA-G, either soluble or present on the surface of tumor-derived EV, is able to up-regulate PD-1 expression on T lymphocytes upon interaction with ILT2, it is tempting to speculate that the inhibition of this pathway may restore T cell cytotoxic activities against tumor cells. Here, HLA-G is linked to neoplasm.